Morphic Demonstrates Novel Real-Time Visualization of Small globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
-Reported positive results from EMERALD-1 phase 2a trial of MORF-057 in ulcerative colitis - -Enrollment on target in EMERALD-2 phase 2b global randomized trial of MORF-057 in UC- .
26.09.2023 - WALTHAM, Mass., Sept. 26, 2023 (GLOBE NEWSWIRE) - Morphic Holdings Inc. (Nasdaq: MORF) today announced that Chief Executive Officer Dr. Praveen Tipirneni suffered an emergent medical event and is taking a medical leave of absence. Dr. Tipirneni is .